All Industries

Top Drug Discovery Companies

1,077 Drug Discovery companies, sorted by total funding raised.

PharmionAcquired

Biotechnology company focused on acquiring, developing and commercializing innovative products in...

Boulder, United States201–500Biotech, Drug Discovery
Series BTotal funding$105.0MNov 2002
Alys Pharmaceuticals

Alys Pharmaceuticals is an immuno-dermatology company developing treatments for atopic dermatitis...

Biotech, Drug Discovery
SeedTotal funding$100.0MFeb 2024
CytoReason

AI-powered drug discovery platform

Tel Aviv, Israel51–200Artificial Intelligence, Biotech
Series BTotal funding$100.0MJul 2024
K36 Therapeutics

K36 Therapeutics develops selective NSD2 inhibitors, including KTX-1001, to treat cancers driven ...

New York, United States1–10Biotech, Drug Discovery
Series BTotal funding$100.0MJun 2023
Lab1636

Harvard-Deerfield joint translational life science R&D company advancing university innovations t...

New York, United StatesBiotech, Drug Discovery
SeedTotal funding$100.0MMar 2019
IconOVir Bio

IconOVir Bio is a biotechnology company pioneering next-generation oncolytic virus therapies to t...

San Diego, United States11–50Biotech, Drug Discovery
Venture RoundTotal funding$97.2MJun 2024
PillPackAcquired

PillPack is an online pharmacy that simplifies medication management by pre-sorting and deliverin...

Manchester, United States501–1000Drug Discovery, E-Commerce
Series DTotal funding$93.5MSep 2016
Orbis Medicines

Orbis Medicines designs oral macrocycle drugs called nCycles using its nGen platform to replace i...

Copenhagen, Denmark11–50Biotech, Drug Discovery
Series BTotal funding$93.0MJan 2025
Pharmaceutics InternationalAcquired
Drug Discovery, Healthcare
Growth EquityTotal funding$93.0MSep 2016
Phil

Software therapy deployment platform simplifying prescription management, delivery, and patient a...

San Francisco, United States51–200Drug Discovery, Healthcare
Series DTotal funding$91.0MJun 2021
TwoStep Therapeutics

TwoStep Therapeutics is developing a pipeline built around a versatile peptide that selectively b...

San Carlos, United States1–10Biotech, Drug Discovery
Series ATotal funding$90.1MSep 2026
Regor

Regor Therapeutics Group is a clinical-stage biotechnology company that discovers and optimizes p...

Cambridge, United StatesBiotech, Drug Discovery
Series BTotal funding$90.0MFeb 2021
Manifold Bio

Manifold Bio builds a high-throughput in vivo discovery engine that combines multiplexed screenin...

Cambridge, United States1–10Biotech, Drug Discovery
Extension RoundTotal funding$89.4MJan 2024
Maxion Therapeutics

Biotech developing antibody-based KnotBody therapeutics targeting ion channels and GPCRs to treat...

Cambridge, United Kingdom11–50Life Sciences, Biotech
Series ATotal funding$88.0MMar 2025
ApreaIPO

Develops small molecule therapeutics for cancer by reactivating mutant p53

DOYLESTOWN, United States11–50Biotech, Oncology
Venture RoundTotal funding$87.0MApr 2026
Amicus TherapeuticsAcquired

Oral pharmacological chaperone protein therapies to address diseases that result from protein mis...

Cranbury, United States501–1000Biotech, Drug Discovery
Venture RoundTotal funding$86.0MJan 2006
ReceptosAcquired

Biopharmaceutical company that developed immune-inflammatory therapies, notably ozanimod (RPC-106...

San Diego, United States51–200Biotech, Drug Discovery
Venture RoundTotal funding$85.8MMar 2012
Tempest TherapeuticsIPO

A clinical-stage oncology company advancing small molecules that combine both targeted and immune...

Brisbane, United States11–50Biotech, Drug Discovery
Private EquityTotal funding$85.0MApr 2022
Ractigen Therapeutics

Clinical-stage Chinese biopharmaceutical company developing RNA activation (RNAa) and siRNA thera...

51–200Drug Discovery, Healthcare
Venture RoundTotal funding$78.0MJul 2026
Notable LabsIPO

Personalized drug discovery for blood cancer.

Foster City, United States11–50Biotech, Drug Discovery
Venture RoundTotal funding$77.4MFeb 2023
Ensem Therapeutics

Pioneer in drug discovery leveraging Kinetic Ensemble platform for oncology precision medicines

Waltham, United States11–50Biotech, Drug Discovery
Extension RoundTotal funding$77.0MOct 2023
Ablaze PharmaClosed

Public company, acquired by Bristol Myers Squibb

Biotech, Healthcare
Series ATotal funding$75.0MNov 2021
Abzena

Abzena helps biotechnology and pharmaceutical innovators develop complex biologics and bioconjuga...

Biotech, Drug Discovery
Growth EquityTotal funding$75.0MMar 2022
NimbleRx

NimbleRx (a Swoop company) provides digital pharmacy technology that modernizes workflows for ind...

Redwood City, United States51–200Healthcare, SaaS
Venture RoundTotal funding$74.8MJun 2022
CinRx Pharma
Biotech, Drug Discovery
Series BTotal funding$73.0MMay 2024